RESMED INC (RMD) research
RESMED INC- Sector
- Health Care
- Industry
- Health Care Equipment
- Last price
- $221.97
- As of
RESMED INC (RMD): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-01.
As of . Source: SEC EDGAR filings for RMD. Method and limitations.
Share the RMD intelligence card
See RMD live in the terminal
Track RMD's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live RMD terminal, freeActive signals for RMD
- highCONSENSUS_SELL
3 tracked funds reduced RMD this 2026Q2, institutional consensus
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 93% of RMD (2026Q2)
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 84% of RMD (2026Q2)
- highINSTITUTIONAL_EXIT
RENAISSANCE TECHNOLOGIES LLC cut 99% of RMD (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +581% to RMD (2026Q2)
FREE, NO ACCOUNT
Every signal on RMD, as it fires
You are seeing 5 of 54 signals recorded on RMD since 2026-05-02.
The five above landed across 2 days. The other 49 were recorded on 5 other days. 52 of the 54 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in RMD (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| CITADEL ADVISORS LLCCUSIP 761152107 · 2026Q2 | $99.1M | 0.01% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 761152107 · 2026Q2 | $80.1M | 0.06% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 761152107 · 2026Q2 | $39.9M | 0.01% | , |
| Bridgewater Associates, LPCUSIP 761152107 · 2026Q2 | $13.1M | 0.05% | , |
| D. E. Shaw & Co., Inc.CUSIP 761152107 · 2026Q2 | $1.2M | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 761152107 · 2026Q2 | $316K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, RMD
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
RMD against its peers
RMD's operating margin of 33.4% ranks in the 97th percentile of 14 Health Care Equipment sub-industry peers, fiscal periods ending between 2025-12-28 and 2026-06-30.
| Metric | RMD | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 5.7B USD | 9.1B USD | 30 | 14 |
| Revenue YoY | 9.9% | n/a | n/a | 1 |
| Gross margin | 61.1% | 62.9% | 41 | 10 |
| Operating margin | 33.4% | 18.1% | 97 | 14 |
| Net margin | 26.9% | 13.2% | 90 | 14 |
| Return on equity | 23.1% | 12.2% | 83 | 14 |
| P / E | 21.3x | 32.6x | 11 | 13 |
Peers (14): DXCM, GEHC, IDXX, EW, STE, ZBH, BSX, RVTY, BAX, SYK, PODD, MDT, ISRG, ABT. Left out: BDX (no annual filing). Fiscal periods ending between 2025-12-28 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (RMD: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more RMD signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to RMDand get the insider, 13F, options, and confluence read in one view.